-
Document de presse | 2015.03.16
Chambéry babies – Official recognition of the new bacterium identified by the Institut Pasteur, Rouxiella chamberiensis
Following the death of three newborns at Chambéry hospital (France) in December 2013, scientists at the Institut Pasteur quickly drew connections to a previously unknown bacterium responsible for the contamination of parenteral nutrition bags. Today, these scientists are publishing an article to announce the official recognition and complete characterization of this bacterium, which belongs to an...
-
Document de presse | 2015.03.23
The Institut Pasteur Announces an Alliance with IntegraGen to Strengthen its High-Throughput Sequencing Activities in Microbiology
As a result of partnership agreement, IntegraGen will be the main operator of high-throughput sequencing activities for the French National Reference Center (NRC) and microbiological collections at the Institut Pasteur. High-throughput sequencing will be the reference tool for analysis, surveillance and diagnostic activities associated with the above in line with the public health mission of the...
-
Document de presse | 2015.04.15
Ferring and the Institut Pasteur collaborate in novel IBD drug development project
Ferring Pharmaceuticals a research-driven, specialty biopharmaceutical group and the Institut Pasteur, a non-profit international biomedical research center in Paris (France) today announced a collaboration aimed at identifying and developing bacteriophages to treat patients suffering from inflammatory bowel disease (IBD). Press release Paris, France/Saint-Prex, Switzerland, April 16,...
-
Document de presse | 2015.04.29
The Médecine-Sciences Program: combining science and medicine to train tomorrow's leaders in biomedical research
Recent scientific breakthroughs and technological advances have fundamentally transformed the practice of medicine and biomedical research. To keep step with this changing environment, it is vital to provide specific scientific training for medical and pharmacy students with an interest in research. To that end, the École Normale Supérieure (ENS), the Institut Pasteur, the Institut Curie, ESPCI...
-
Document de presse | 2015.05.05
The Institut Pasteur and Stragen sign an exclusive worldwide license agreement for first-in-class pain management dual enkephalinase inhibitor (DENKI) novel compound
The Institut Pasteur, a private non-profit international biomedical research center based in Paris (France), and Stragen, privately-owned, international healthcare company based in Geneva (Switzerland), announced today that they have entered together into an exclusive worldwide license for intellectual property, related to derivatives of endogenous dual enkephalinase inhibitor (DENKI) novel...
-
Document de presse | 2015.05.06
Viagra to prevent transmission of the malaria parasite?
By increasing the stiffness of erythrocytes infected by the causal agent of malaria, Viagra favors their elimination from the blood circulation and may therefore reduce transmission of the parasite from humans to mosquitoes. This astonishing discovery, made by scientists from the CNRS, INSERM, Université Paris Descartes – at the Institut Cochin – and the Institut Pasteur, working in...
-
Document de presse | 2015.05.17
Premature aging: scientists identify and correct defects in diseased cells
Scientists from the Institut Pasteur and CNRS, in collaboration with scientists from the Institut Gustave Roussy and CEA, have succeeded in restoring normal activity in cells isolated from patients with the premature aging disease Cockayne syndrome. They have uncovered the role played in these cells by an enzyme, the HTRA3 protease. This enzyme is overexpressed in Cockayne syndrome patient cells...
-
Document de presse | 2015.05.25
Kurma Partners announces the launch of its third fund Kurma Diagnostics (KDx)
The European Investment Fund (EIF), Fonds National d’Amorçage (FNA) managed by Bpifrance as part of the French government’s Investments for the future (“Investissements d’Avenir”) program, Institut Pasteur, and BNP Paribas are participating in the first closing (€33M). Press release Paris, May 26, 2015 Kurma Diagnostics: the first Venture Capital...
-
Document de presse | 2015.05.27
Institut Pasteur's involvement in the fight against Ebola
The Institut Pasteur and the Institut Pasteur International Network are assisting the international aid effort by offering diagnostic support and epidemiological surveillance in collaboration with the Guinean Ministry of Health. The Institut Pasteur teams in the WHO Collaborating Center for Viral Hemorrhagic Fevers and Arboviruses are closely involved in the Ebola response. From identification of...
-
Document de presse | 2015.06.15
Restoring natural immunity against cancers
Scientists at the Institut Pasteur and Inserm have successfully increased the infiltration of immune cells into tumors, thus inducing the immune system to block tumor growth. In an article published in Nature Immunology, the scientists show that, in combination with existing immunotherapies, this process efficiently destroys cancer cells. Pess release Paris, June 16, 2015 ...
